Home LiteratureArticle Details
PMID: 2263897 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The epidemiology of trachoma predicts more blindness in the future.

Scandinavian journal of infectious diseases. Supplementum ·Vol. 69 ·1990-00-00 ·Pages 55-62

Schachter J, Dawson CR

Abstract

Trachoma is considered the world's leading preventable cause of blindness, with hundreds of millions of people affected and approximately 6 to 9 million blinded as a result of the disease. It was once endemic in much of the world. It disappeared from most of Europe and North America, coincident with the improvements in hygienic conditions that accompanied the expanding industrial revolution in the latter part of the 19th century. Common wisdom states that trachoma is disappearing from much of the world today as a result of improvement in the standard of living. Unfortunately, this is not a realistic perception. In some hyperendemic areas neither the standard of living nor hygienic conditions are improving. Deaths due to acute infections have been reduced and the population is both growing and aging. In some parts of the world, because of demographics, it is likely that there are more people being exposed to trachoma as children and more will survive to old age when trachomatous blindness develops. In these countries there will be larger numbers of blind individuals in the future than there are today. This will tax public health and economic systems in the involved communities.

MeSH Terms
Blindness/epidemiology,etiology Developing Countries Egypt/epidemiology Global Health Humans Trachoma/complications,epidemiology Tunisia/epidemiology
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Schachter J
Department of Laboratory Medicine, University of California, San Francisco.
Dawson C R
Article Info
Journal
Scandinavian journal of infectious diseases. Supplementum
Abbr.
Scand J Infect Dis Suppl
ISSN
0300-8878
Published
1990-00-00
Pages
55-62
Language
English
Region
England
NLM ID
0251025
Subset
IM
Grants
NEI NIH HHS · EY-00427 · United States
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com